Novartis To Shutter San Francisco Antibiotics Research Facility.

Bloomberg News (7/11, Kasumov) reports Novartis AG announced it “will shut down its antibacterial and antiviral research operations in the San Francisco Bay area and cut about 140 jobs.” The move comes as the drug maker plans “to narrow its R&D focus und...